Stocks · Healthcare · Biotechnology
Rhythm Pharmaceuticals, Inc. RYTM
$92.83 -0.62% Close, Oct 2, 2026 · NASDAQ · Market cap $6.37B
Strong growth
Next earnings report: Nov 3, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -83.6% from -113.5% a year earlier.
- Revenue over the last four quarters was $239.9M, up 53.5% from a year earlier, slowing from 58.7% a quarter earlier.
- The diluted share count rose 7.7% in a year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 16%
- Revenue growth, 3-year CAGRTop 8%
- Revenue growth accelerationBottom 25%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 19%
- Gross marginTop 20%
- Operating marginBottom 31%
- Accruals (lower is better)Top 27%
- Interest coverBottom 32%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 39%
- Free-cash-flow yieldTop 43%
- EBITDA / enterprise valueTop 46%
- Sales / enterprise valueBottom 18%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 38%
- 6-month returnTop 49%
- 1-year return vs S&P 500Bottom 38%
- Distance from 52-week highTop 38%
- Trend checklist (0–4)Bottom 38%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 45%
- Consecutive EPS beatsTop 25%
- Share of analysts rating BuyTop 10%
- Upside to consensus price targetBottom 46%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 20%
- Maximum drawdown, 3 yearsTop 9%
- Beta vs S&P 500 (lower is better)Bottom 20%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 58.7% | 53.5% | ↓ |
| Gross margin | 89.2% | 89.0% | ↓ |
| Operating margin | -113.5% | -83.6% | ↑ |
| FCF margin | -68.9% | -62.7% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 53.5% | 58.7% | ↓ | Top 16% |
| Gross margin | 89.0% | 89.2% | ↓ | Top 20% |
| Operating margin | -83.6% | -113.5% | ↑ | Bottom 31% |
| Net margin | -85.6% | -117.1% | ↑ | — |
| Free-cash-flow margin | -62.7% | -68.9% | ↑ | — |
| Return on invested capital | -63.8% | — | Bottom 19% | |
| Revenue growth, 3-year CAGR | 100.2% | — | Top 8% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -12.8%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 46.0%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +1.2 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -10.9×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -3.34%
- Shareholder yield
- -3.34%
- Share count change, 1 year
- +7.7%
- Share count change, 3-year CAGR
- +6.4%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 4, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 3
- Beats in the last 8 reports
- 4 of 8
- Average EPS surprise, last 4
- +1.7%
- Average 2-day reaction, last 8
- +1.7%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $143.83
- Target vs current price
- +54.9%
- Analysts with a rating
- 22
- Share rating Buy or Strong Buy
- 100%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 4, 2026 | +9.6% | +2.9% | +12.4% | +3.3% | — |
| May 5, 2026 | +3.5% | +7.9% | +2.1% | -1.4% | +23.6% |
| Feb 26, 2026 | +7.6% | -1.1% | -8.2% | -14.7% | -9.0% |
| Nov 4, 2025 | -13.9% | -7.7% | -14.2% | -10.9% | -9.9% |
| Aug 5, 2025 | -13.6% | -1.9% | +4.5% | +15.5% | +25.7% |
| May 7, 2025 | -17.4% | +3.1% | -9.4% | +2.7% | +40.8% |
| Feb 26, 2025 | -4.3% | +4.5% | +4.3% | +3.7% | +22.3% |
| Nov 5, 2024 | +8.8% | +6.2% | +23.8% | +13.4% | +12.1% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | -$0.73 | -$0.81 | +9.6% | $71.3M |
| May 5, 2026 | -$0.83 | -$0.86 | +3.5% | $60.1M |
| Feb 26, 2026 | -$0.73 | -$0.79 | +7.6% | $57.3M |
| Nov 4, 2025 | -$0.82 | -$0.72 | -13.9% | $51.3M |
| Aug 5, 2025 | -$0.75 | -$0.66 | -13.6% | $48.5M |
| May 7, 2025 | -$0.81 | -$0.69 | -17.4% | $32.7M |
| Feb 26, 2025 | -$0.72 | -$0.69 | -4.3% | $41.8M |
| Nov 5, 2024 | -$0.73 | -$0.80 | +8.8% | $33.3M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 26.28× | — | — | Bottom 18% |
| Free-cash-flow yield | -2.36% | — | — | Top 43% |
| Earnings yield | -3.35% | — | — | Top 39% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -3.8%
- 200-day average slope (20 days)
- -0.7%
- Distance from 50-day average
- -11.9%
- Distance from 200-day average
- -6.1%
- RSI (14)
- 29.3
- Relative volume
- 0.73×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 38.3%
- Volatility vs own 5-year history
- 4th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.77
- Correlation with S&P 500
- 0.46
- Current drawdown from 1-year high
- -21.1%
- Maximum drawdown, 3 years
- -35.5%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jan 22, 2021 | May 19, 2022 | -92.1% | 334 days | 393 days (Dec 12, 2023) |
| Dec 11, 2025 | Mar 27, 2026 | -35.5% | 72 days | Not yet recovered |
| Feb 12, 2024 | May 29, 2024 | -32.5% | 74 days | 32 days (Jul 16, 2024) |
| Nov 8, 2024 | Apr 4, 2025 | -30.3% | 99 days | 43 days (Jun 6, 2025) |
| Dec 27, 2023 | Jan 5, 2024 | -19.9% | 6 days | 24 days (Feb 9, 2024) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $6.37B
- EPS, diluted (TTM)
- -$3.11
- Revenue (TTM)
- $239.9M
- 52-week range
- $74.50 – $122.20
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $3.2M | $23.6M | $77.4M | $130.1M | $189.8M |
| Gross profit | $2.6M | $21.5M | $68.1M | $116.8M | $170.3M |
| Operating income | -$170.1M | -$179.2M | -$184.4M | -$265.5M | -$192.0M |
| Net income | -$69.6M | -$181.1M | -$184.7M | -$260.6M | -$196.5M |
| EPS (diluted) | -$1.37 | -$3.51 | -$3.20 | -$4.34 | -$3.11 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $33.3M | $41.8M | $32.7M | $48.5M | $51.3M | $57.3M | $60.1M | $71.3M |
| Net income | -$43.6M | -$43.3M | -$49.5M | -$46.6M | -$52.9M | -$47.5M | -$55.6M | -$49.3M |
| EPS (diluted) | -$0.71 | -$0.72 | -$0.81 | -$0.75 | -$0.82 | -$0.73 | -$0.83 | -$0.73 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$146.0M | -$173.4M | -$136.2M | -$113.9M | -$115.7M |
| Capital expenditure | -$5.4M | -$4.3M | -$47,000 | $0 | -$953,000 |
| Free cash flow | -$151.4M | -$177.7M | -$136.2M | -$113.9M | -$116.6M |
| Dividends paid | $0 | $0 | $0 | -$4.0M | $0 |
| Net share buybacks | $161.7M | $131.1M | $48.9M | $195.2M | $237.9M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $330.9M
- Total assets
- $437.3M
- Total liabilities
- $220.0M
- Total debt
- $3.7M
- Net debt
- -$61.9M
- Shareholders’ equity
- $217.3M
As of Jun 30, 2026 (filed Aug 4, 2026).
Short interest
- Shares sold short
- 10,287,811
- Days to cover
- 20.06
- Change vs previous report
- -0.1%
FINRA short interest, settlement date Sep 15, 2026.